ProAgio Dose Levels (DL) 1,2,3,4 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: ACT50, Gemcitabine

Filter by location:

Birmingham, Alabama1 trial

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

O'Neal Comprehensive Cancer Center, University of Alabama

Phase 1

Atlanta, Georgia1 trial

ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Emory University Winship Cancer Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.